Target intelligence / Profile preview

Retinal cell surface receptors for engineered AAV capsids

Molecular classification
Receptor, Other
01

Overview

Retinal cell surface receptors and attachment factors for engineered Adeno-Associated Virus (AAV) capsids are the molecular entities that mediate the binding and entry of synthetic viral vectors into retinal cells. While the Adeno-associated virus receptor (AAVR or KIAA0319L) has been identified as a universal entry factor for most natural AAV serotypes (Pillay et al., 2016, Nature), engineered capsids often utilize distinct, unidentified receptors to improve retinal penetration. For instance, the engineered AAV2-7m8 variant was designed to bypass the inner limiting membrane, yet its specific high-affinity binding partners in the outer retina remain largely uncharacterized (Dalkara et al., 2013, Science Translational Medicine). These unidentified factors are critical for the success of gene therapies targeting inherited retinal degenerations, such as Leber congenital amaurosis or retinitis pigmentosa. In these applications, the AAV capsid acts as the delivery vehicle that targets these surface molecules to internalize genetic payloads. Identifying these specific molecules is a significant challenge in the field, as it would allow for more precise engineering of vectors for treating inherited retinal diseases. Currently, the interaction between engineered capsids and these unknown surface factors is the primary mechanism for delivering corrective genes in clinical and preclinical ocular therapies (Huang et al., 2023, Nature Communications).

Other names
Unidentified retinal AAV receptorsAAV attachment factorsEngineered AAV binding partnersRetinal AAV entry factorsAAV capsid receptors
02

Mechanism of action

Facilitation of viral attachment and internalization into retinal cells for gene delivery

03

Biological functions

Viral entryCell-virus interactionEndocytosisCellular internalization
04

Disease associations

Retinal dystrophiesInfectionGenetic disorders
05

Safety considerations

Immunogenicity against the viral capsidOff-target transduction of non-target retinal cellsLimited penetration of the inner limiting membraneInflammatory response to viral entryNeutralizing antibodies
06

Interacting drugs

Voretigene neparvovec

4 more in the full profile.

Beyond the preview

Go deeper on Retinal cell surface receptors for engineered AAV capsids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinal cell surface receptors for engineered AAV capsids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call